Extended-release tacrolimus tablets for preventing organ transplant rejection

References

• Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2013 annual data report: kidney. Am J Transplantat. 2015 Jan;15(Suppl 2):1–34.
   PubMed Web of Science ®Google Scholar
• Introduction. Am J Transplant. 2014;14(S1):8–10. doi:10.1111/ajt.12578
   PubMed Web of Science ®Google Scholar
• Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995 Dec;17(6):584–591.
   PubMed Web of Science ®Google Scholar
• Jiang H, Xiong F, Kong S, et al. Distinct tissue and cellular distribution of two major isoforms of calcineurin. Mol Immunol. 1997 Jun;34(8–9):663–669.
   PubMed Web of Science ®Google Scholar
• Kung L, Batiuk TD, Palomo-Pinon S, et al. Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am J Transplantat. 2001 Nov;1(4):325–333.
   PubMed Web of Science ®Google Scholar
• Hebert MF. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev. 1997 Sep 15; 27(2–3):201–214.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Makuuchi M, Harihara Y, et al. Correlation between neurotoxic events and intracerebral concentration of tacrolimus in rats. Biol Pharm Bull. 2000 Aug;23(8):1008–1010.
   PubMed Web of Science ®Google Scholar
• Yokogawa K, Takahashi M, Tamai I, et al. P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. Pharm Res. 1999 Aug;16(8):1213–1218.
   PubMed Web of Science ®Google Scholar
• Dawson TM, Steiner JP, Lyons WE, et al. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. Neuroscience. 1994 Sep;62(2):569–580.
   PubMed Web of Science ®Google Scholar
• Barbarino JM, Staatz CE, Venkataramanan R, et al. PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics. 2013 Oct;23(10):563–585.
   PubMed Web of Science ®Google Scholar
• Jusko WJ, Piekoszewski W, Klintmalm GB, et al. Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther. 1995 Mar;57(3):281–290.
   PubMed Web of Science ®Google Scholar
• Jusko WJ, Thomson AW, Fung J, et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit. 1995 Dec;17(6):606–614.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsuno N, Senuma K, et al. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter–why cyclosporine is monitored by C(2) level and tacrolimus by trough level. Biol Pharm Bull. 2008 Jan;31(1):90–94.
   PubMed Web of Science ®Google Scholar
• Undre NA. Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial Transplant. 2003 May;18(Suppl 1):i12–5.
   Google Scholar
• Hochleitner BW, Bosmuller C, Nehoda H, et al. Increased tacrolimus levels during diarrhea. Transpl Int. 2001 Aug;14(4):230–233.
   PubMed Web of Science ®Google Scholar
• Tsunashima D, Kawamura A, Murakami M, et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. Clin Ther. 2014 May;36(5):748–759.
   PubMed Web of Science ®Google Scholar
• Alloway RR, Mulgaonkar S, Ueda K, et al. A phase 2 randomized study of the pharmacokinetics, safety and efficacy of LCP-tacro tabples once-a-day vs. Prograf capsules twice-a-day in de novo kidney transplants. Am J Transplant. 2011;11:e355.
   Web of Science ®Google Scholar
• Grinyo JM, Petruzzelli S. Once-daily LCP-tacro meltdose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. Expert Rev Clin Immunol. 2014 Dec;10(12):1567–1579.
   PubMed Web of Science ®Google Scholar
• Gaber AO, Alloway RR, Bodziak K, et al. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. Transplantation. 2013 Jul 27; 96(2):191–197.
   PubMed Web of Science ®Google Scholar
• Tremblay S, Nigro V, Weinberg J, et al. A steady-state head-to-head pharmacokinetic comparison of all FK-506 (Tacrolimus) formulations (ASTCOFF): an open label, prospective, randomized, two arm, three period crossover study. Am J Transplant. 2016. doi:10.1111/ajt.13935.
   Google Scholar
• Tanzi MG, Undre N, Keirns J, et al. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients. Clin Transplant. 2016;30(8):901–911.
   PubMed Web of Science ®Google Scholar
• Budde K, Bunnapradist S, Grinyo JM, et al. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of phase III, double-blind, randomized trial. Am J Transplantat. 2014 Dec;14(12):2796–2806.
   PubMed Web of Science ®Google Scholar
• Rostaing L, Bunnapradist S, Grinyó JM, et al. Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial. Am J Kidney Dis. 2016;67(4):648–659.
   PubMed Web of Science ®Google Scholar
• Bunnapradist S, Ciechanowski K, West-Thielke P, et al. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplantat. 2013 Mar;13(3):760–769.
   PubMed Web of Science ®Google Scholar
• Bunnapradist S, Rostaing L, Alloway RR, et al. LCPT once-daily extended-release tacrolimus tablets Vs. Twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups. Transpl Inter. 2016 Mar 8;29(5):603–611.
   PubMed Web of Science ®Google Scholar
• Roy J-N, Lajoie J, Zijenah LS, et al. CYP3A5 genetic polymorphisms in different ethnic populations. Drug Metab Dispos. 2005 Jul 1;33(7):884–887.
   PubMed Web of Science ®Google Scholar
• Haufroid V, Wallemacq P, VanKerckhove V, et al. CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant. 2006;6(11):2706–2713.
   PubMed Web of Science ®Google Scholar
• Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc. 1991 Dec;23(6):3175–3178.
   PubMed Web of Science ®Google Scholar
• Langone A, Steinberg SM, Gedaly R, et al. Switching study of kidney transplant patients with tremor to LCP-tacro (STRATO): an open-label, multicenter, prospective phase 3b study. Clin Transplant. 2015 Sep;29(9):796–805.
   PubMed Web of Science ®Google Scholar
• Hess CW, Pullman SL. Tremor: clinical phenomenology and assessment techniques. Tremor Other Hyperkinet Mov. 2012;2: tre-02-65-365-1.
   PubMedGoogle Scholar
• Trofe-Clark J, Brennan D, West-Thielke P, et al. comparison of pharmacokinetics and pharmacogenomics of once-daily extended-release meltdose® tacrolimus tablets (Envarsus® XR) Vs. Twice-daily tacrolimus capsules in stable African American kidney transplant patients: a randomized cross-over study. Am J Transplant. 2015;15(S3):1(abs 343).
   PubMed Web of Science ®Google Scholar
• Trofe-Clark J, Brennan D, West-Thielke P, et al. A randomized cross-over phase 3b study of the pharmacokinetics of once-daily extended release meltdose® tacrolimus (Envarsus® XR) versus twice-daily tacrolimus in African-Americans (ASERTAA). Am J Transplant. 2015;15(S3):1(abs 256).
   PubMed Web of Science ®Google Scholar
• clinicaltrials.gov. Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients (STEADY); 2016 [cited 2016 Jun 21]. Available from: https://clinicaltrials.gov/show/NCT02432833.
   Google Scholar
• Veloxis pharmaceuticals v United States food and drug administration ea [Internet]. 57 ed. 2015. 31. [cited 2016 Aug 5]. Available from: http://law.justia.com/cases/federal/district-courts/district-of-columbia/dcdce/1:2014cv02126/169485/57/
   Google Scholar